Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 11,000

Document Document Title
WO/2017/024639A1
A Chinese medicine hangover curing agent. The agent is prepared from Chinese Hawthorn, Folium nelumbinis, Folium mori, Taraxaci herba, Lophatheri herba, common duckweed and tangerine leaves.  
WO/2017/022030A1
Provided is a method for producing an extract of Momordica charantia var. pavel, said extract containing less than 5 ppm of quinine. The method for producing an extract of M. charantia var. pavel comprises a cultivation step, a harvestin...  
WO/2017/021914A1
This document provides methods and materials for reducing the degree of damage to tissue transplanted into a mammal following transplantation. For example, methods and materials for using abscisic acid to reduce tissue damage to vascular...  
WO/2017/014340A1
The present invention relates to a composition containing Stephanandra incisa (Thunb.) Zabel extracts having an anti-aging efficacy and a use containing the same as an active ingredient. The present invention provides Stephanandra incisa...  
WO/2017/013492A1
The present disclosure provides compositions comprising 15-HEPE for use in treating and/or preventing cancer and neurological diseases in a subject in need thereof.  
WO2017010538A1
Provided are a carnosine dipeptidase 1 inhibitor composition, a use for a material that inhibits carnosine dipeptidase 1, and a method for inhibiting carnosine dipeptidase 1. The present invention demonstrates the discovery of a plant- o...  
WO2017008902A1
Pharmaceutically acceptable cholecalciferol sulfate salts are used for combating vitamin D3deficiency. The invention also relates to cholecalciferol sulfate salts and to pharmaceutical compositions of the pharmaceutically acceptable chol...  
WO2017010133A1
Provided are a carnosine dipeptidase 1 inhibitor composition, a use for a material that inhibits carnosine dipeptidase 1, and a method for inhibiting carnosine dipeptidase 1. The present invention demonstrates the discovery of a plant- o...  
WO/2017/009202A1
This invention relates generally to compositions and methods for combating inflammatory disease and particularly to the use of food and/or feed compositions for preventing, reducing and/or treating inflammatory disorders, diseases, or di...  
WO2017010537A1
Provided are a carnosine dipeptidase 1 inhibitor composition, a use for said composition in order to inhibit carnosine dipeptidase 1, and a method for inhibiting carnosine dipeptidase 1. The present invention demonstrates the discovery o...  
WO/2016/206363A1
A use of a Jilin ginseng oligopeptide in preparation of an anti-oxidant food product or a health care food product.  
WO/2016/210226A1
The present invention provides a formulation of Coenzyme Q10 that can be re-dispersed from a stable dry powder to formulation to yield a nanodispersion that can be readily aerosolized for inhalation.  
WO/2016/198401A1
A series of substituted indazole derivatives, being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neuro...  
WO/2016/188766A1
The present invention relates to compounds for prophylaxis or treatment of organ damage by restoring endothelial function and/or inhibiting reactive oxygen species production and especially to compounds for prophylaxis or treatment of di...  
WO/2016/190750A1
Improving the antioxidant capacity in an animal by increasing the level of glutathione in the blood or tissue of the animal comprising providing a composition containing beta- casein to the animal for consumption, where the beta-casein c...  
WO/2016/187545A1
This invention relates to compositions and methods for treating, ameliorating and preventing the toxic effects of venom poisoning. In particular, the invention provides compositions comprising carbon monoxide releasing molecules (CORM) o...  
WO/2016/185403A1
The present application refers to the development of a new effective antidote for the poisonous Amanita mushroom species, after exploring an innovative in silico and in vivo approach based on the binding site of amatoxin to RNA polymeras...  
WO/2016/177309A1
Provided is a method for preparing a broccoli protein peptide. The method uses a broccoli protein as the raw material, and obtains a broccoli protein peptide powder through the steps of preprocessing, enzymatic hydrolysis, terminating en...  
WO/2016/174367A1
The present invention relates to a bioassimilable protein-melanin complex, advantageously soluble in water, comprising a protein extract, advantageously rich in S-sulfonated residues and melanin. The claimed complex further exhibits subs...  
WO/2016/171640A1
The invention relates to pharmacology and may be used for producing medicinal agents for treating and preventing viral diseases caused by the herpes, influenza and hepatitis B and C viruses, and also virus-induced immunodeficiencies. A b...  
WO/2016/169353A1
A compound beverage for clearing heat and a preparation method therefor. The compound beverage is prepared from the following components in parts by weight: 15 to 20 parts of white fungus, 3 to 7 parts of bulbus lilii, 1 to 5 parts of se...  
WO/2016/168670A3
The present disclosure relates to methods of extending the lifespan of a subject or treating, suppressing, inhibiting or delaying the onset of an age-related condition or disorder, such as cancer, in a subject. The methods comprise admin...  
WO/2016/161501A1
The present application provides pharmaceutical compositions comprising polyanionic and polynon-ionic cyclodextrin-based dendrimers. The compositions can be used as excipients, or to bind to compounds such as in the use as a rescue medic...  
WO/2016/162870A1
Inhibitor compounds and agents of Cathepsin C, CELA1, CELA3A and/or structurally related molecules thereto, compositions comprising same and uses thereof in the inhibition and/or prevention of cell and/or tissue necrosis is described. Va...  
WO/2016/149886A1
Uses of a multipolar microkinetic drinking water in preparing a drink, healthcare product or medicament for use in reducing blood urea. The multipolar microkinetic drinking water is prepared from raw drinking water being passed through a...  
WO/2016/149885A1
Uses of a multipolar microkinetic drinking water in preparing a drink, healthcare product or medicament for reducing blood urea. The multipolar microkinetic drinking water is prepared from raw drinking water being passed through an elect...  
WO/2016/147185A1
Novel adenosine 5'-thiophosphate derivatives, represented by Formulae (I) or (I*), and salts thereof, represented by Formulae (Ia) and (I*a), as defined in the specification, and uses thereof as antioxidants and/or P2Y1-R agonists, and/o...  
WO/2016/148202A1
Provided is a method for producing functional mineral water having antioxidative effect and other effective indications. Provided is a method for producing functional mineral water containing: a mineral-containing water (A) that contains...  
WO/2016/149424A1
Compositions comprising apple, grape, green tea, and olive extracts are presented herein. This synergistic formulations apple, grape, green tea, and olive extract are in amounts that provide a greater antioxidant activity or protein kina...  
WO/2016/145911A1
An application of nicotinamide mononucleotide in the preparation of an anti-aging drug or health care product, a single dose of nicotinamide mononucleotide being 1-500mg/kilogram of body weight/day, the drug or health care product being ...  
WO/2016/146573A1
Compositions comprising melatonin and/or derivatives thereof are provided for topical administration to the epithelium of the urinary bladder by instillation into the bladder to protect against or treat bladder injury due to irradiation ...  
WO/2016/146042A1
The present invention provides a zinc binding fusion protein that is a fusion protein of glutathione S-transferase (GST) and metallothionein (MT) binding to zinc, which provides an efficacy in preventing or treating a ROS-related disease...  
WO/2016/142580A1
The present invention concerns a non-toxic solid pharmaceutical composition for oral administration for use in preventing hangover symptoms, wherein the composition contains one or more cysteine compounds from the group of L-cysteine, D-...  
WO/2016/141775A1
Uses of Jilin ginseng oligopeptide in preparing a food product or healthcare food product for combating fatigue.  
WO/2016/142341A1
Compositions comprising melatonin or derivatives thereof are provided for topical administration to the vaginal and/or rectal epithelium to protect against vaginal and/or rectal radiation injury due to radiotherapy.  
WO/2016/141315A1
Provided are methods of treating skin with at least two alternating treatment modalities to improve the health and/or diminish signs of aging. Some methods according to the present invention may comprise topically applying at least two s...  
WO/2016/135666A1
This invention relates to a liquid aqueous composition liquid aqueous composition for the prevention, reduction and/or treatment of burns caused by contacting of the skin of a body part of a human or animal with one or more chemicals, wh...  
WO/2016/131972A1
The invention relates to the use of Dasatinib in the preparation of a drug for treating a mammal exposed to radiation, in particular abdominopelvic radiation exposure, for preventing, limiting, reducing and/or eliminating the early or la...  
WO/2016/131333A1
Provided are an antioxidant complex for reducing the number of somatic cells in a livestock animal and a preparation method and application thereof. Active components of the preparation are melatonin (MT) having a concentration of 2-30 g...  
WO/2016/130927A1
Disclosed herein are compounds of the formula: (I), wherein the variables are defined herein. Also provided are pharmaceutical compositions thereof. In some aspects, the compounds and compositions provided herein may be used as antioxida...  
WO/2016/127896A1
Disclosed is an application of an antibacterial peptide C-BF in preparation of a drug for preventing and treating stress of weaned piglets. The antibacterial peptide C-BF can improve intestinal morphology, increase the height of villi, r...  
WO/2016/124605A1
Compositions comprising melatonin or derivatives thereof for administration to the epithelium of the lower airway to protect against lung damage due to chest irradiation and/or cytotoxic chemotherapy are provided.  
WO/2016/126860A1
Provided are pharmaceutical dosage forms comprising (i) trientine or a pharmaceutically acceptable salt of trientine, in a (ii) sealed packaging. The sealed packaging provides a high barrier protection against air, moisture and light and...  
WO/2016/125006A1
The invention provides an isolated, engineered, non-naturally occurring tissue protective protein or peptide (TPP) comprising a cell penetrating peptide (CPP) fused in frame with a heme oxygenase protein, or a derivative, variant, homolo...  
WO/2016/119143A1
A lutein microcapsule preparation and preparation method, the preparation comprising the following ingredients: lutein crystals, a water-soluble emulsifier, an oil-soluble antioxidant, a wall material, a filler, a water-soluble antioxida...  
WO/2016/118611A1
Bifunctional compounds that increase uric acid excretion and reduce uric acid production, and monofunctional compounds that either increase uric acid excretion or reduce uric acid production. Methods of using these compounds for reducing...  
WO/2016/118878A1
A supplement includes plant-derived phosphatidylserine in a physiologically beneficial amount and at least one plant-based concentrate or extract which promotes a melatonergic benefit.  
WO/2016/114860A1
Compounds, compositions, and methods for treatment of, or prophylaxis against, radiation exposure are disclosed.  
WO/2016/115097A3
The present invention provides methods and compositions for specific activation of inflammatory responses in dendritic cells (DCs). 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphorylcholine (PAPC) and its oxidized variant (oxPAPC) were id...  
WO/2016/115097A2
The present invention provides methods and compositions for specific activation of inflammatory responses in dendritic cells (DCs). 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphorylcholine (PAPC) and its oxidized variant (oxPAPC) were id...  

Matches 1 - 50 out of 11,000